CD274 and non-small cell lung carcinoma: A study by Patel and colleagues finding increased tumor expression of PD-L1 after treatment with VSV–IFNβ in a murine model of non-small-cell lung cancer indicates the potential of PD-1/PD-L1 agents to increase efficacy (65).